مصطلحات الفهرس: drug safety, drug tolerability, dyspnea/si [Side Effect], febrile neutropenia/si [Side Effect], fever/si [Side Effect], human, infection/si [Side Effect], infestation/si [Side Effect], infusion related reaction/dt [Drug Therapy], infusion related reaction/si [Side Effect], monotherapy, nausea/si [Side Effect], neutropenia/si [Side Effect], pharmacodynamic parameters, pharmacokinetic parameters, pharmacological parameters, phase 3 clinical trial (topic), pneumonia/si [Side Effect], priority journal, pruritus/si [Side Effect], rigor/si [Side Effect], tachycardia/si [Side Effect], thrombocytopenia/si [Side Effect], tumor lysis syndrome/si [Side Effect], acalabrutinib/cb [Drug Combination], acalabrutinib/dt [Drug Therapy], bendamustine/dt [Drug Therapy], chlorambucil/ae [Adverse Drug Reaction], chlorambucil/cb [Drug Combination], chlorambucil/dt [Drug Therapy], clarithromycin/it [Drug Interaction], cyclophosphamide/cb [Drug Combination], cyclophosphamide/cm [Drug Comparison], cyclophosphamide/dt [Drug Therapy], fludarabine/cb [Drug Combination], fludarabine/cm [Drug Comparison], fludarabine/dt [Drug Therapy], hydrocortisone/dt [Drug Therapy], ibrutinib/cb [Drug Combination], ibrutinib/cm [Drug Comparison], ibrutinib/dt [Drug Therapy], obinutuzumab/cb [Drug Combination], obinutuzumab/dt [Drug Therapy], posaconazole/it [Drug Interaction], ritonavir/it [Drug Interaction], rituximab/ae [Adverse Drug Reaction], rituximab/cb [Drug Combination], rituximab/cm [Drug Comparison], rituximab/dt [Drug Therapy], venetoclax/ae [Adverse Drug Reaction], venetoclax/cb [Drug Combination], venetoclax/cm [Drug Comparison], venetoclax/it [Drug Interaction], venetoclax/dt [Drug Therapy], obinutuzumab/ae [Adverse Drug Reaction], abdominal pain/si [Side Effect], allogeneic hematopoietic stem cell transplantation, anemia/si [Side Effect], article, backache/si [Side Effect], cancer chemotherapy, cancer immunotherapy, cancer recurrence, chronic lymphatic leukemia/dt [Drug Therapy], chronic lymphatic leukemia/th [Therapy], diarrhea/si [Side Effect], drug efficacy, drug metabolism, drug potentiation, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27245
Future Oncology
Click here for full text options
LibKey Link

مصطلحات الفهرس: pruritus/si [Side Effect], randomized controlled trial (topic), rash/si [Side Effect], respiratory tract infection/si [Side Effect], second cancer/si [Side Effect], skin cancer/si [Side Effect], splenomegaly, subdural hematoma/si [Side Effect], thrombocytopenia/si [Side Effect], upper respiratory tract infection/si [Side Effect], urinary tract infection/si [Side Effect], very elderly, Waldenstroem macroglobulinemia/dt [Drug Therapy], bendamustine/dt [Drug Therapy], chlorambucil/dt [Drug Therapy], cisplatin/dt [Drug Therapy], cyclophosphamide/dt [Drug Therapy], dexamethasone/dt [Drug Therapy], enoxaparin/cb [Drug Combination], hemoglobin/ec [Endogenous Compound], hydrocortisone/dt [Drug Therapy], ifosfamide/dt [Drug Therapy], immunoglobulin M/ec [Endogenous Compound], lomustine/dt [Drug Therapy], melphalan/dt [Drug Therapy], methylprednisolone/dt [Drug Therapy], myeloid differentiation factor 88/ec [Endogenous Compound], ofatumumab/dt [Drug Therapy], prednisolone/dt [Drug Therapy], prednisone/dt [Drug Therapy], rituximab/dt [Drug Therapy], zanubrutinib/ae [Adverse Drug Reaction], zanubrutinib/cb [Drug Combination], zanubrutinib/dt [Drug Therapy], zanubrutinib/tm [Unexpected Outcome of Drug Treatment], MYD88 gene, zanubrutinib/pv [Special Situation for Pharmacovigilance], adult, aged, anemia/si [Side Effect], arthralgia/si [Side Effect], article, atrial fibrillation/si [Side Effect], backache/si [Side Effect], basal cell carcinoma/si [Side Effect], bleeding/si [Side Effect], cellulitis/si [Side Effect], clinical article, constipation/si [Side Effect], contusion/si [Side Effect], coughing/si [Side Effect], decreased appetite/si [Side Effect], diarrhea/si [Side Effect], drug dose reduction, drug efficacy, drug safety, drug withdrawal, fatigue/si [Side Effect], female, fever/si [Side Effect], gene mutation, headache/si [Side Effect], hemoptysis/si [Side Effect], herpes zoster/si [Side Effect], human, hypertension/si [Side Effect], hyponatremia/si [Side Effect], infection/si [Side Effect], laceration/si [Side Effect], lymphadenopathy, male, monotherapy, multicenter study (topic), muscle spasm/si [Side Effect], neutropenia/si [Side Effect], opportunistic infection/si [Side Effect], overall survival, peripheral edema/si [Side Effect], phase 3 clinical trial (topic), pneumonia/si [Side Effect], priority journal, progression free survival, Article

URL: Click here for full text options
LibKey Link

مصطلحات الفهرس: drug safety, drug tolerability, dyspnea/si [Side Effect], febrile neutropenia/si [Side Effect], fever/si [Side Effect], human, infection/si [Side Effect], infestation/si [Side Effect], infusion related reaction/dt [Drug Therapy], infusion related reaction/si [Side Effect], monotherapy, nausea/si [Side Effect], neutropenia/si [Side Effect], pharmacodynamic parameters, pharmacokinetic parameters, pharmacological parameters, phase 3 clinical trial (topic), pneumonia/si [Side Effect], priority journal, pruritus/si [Side Effect], rigor/si [Side Effect], tachycardia/si [Side Effect], thrombocytopenia/si [Side Effect], tumor lysis syndrome/si [Side Effect], acalabrutinib/cb [Drug Combination], acalabrutinib/dt [Drug Therapy], bendamustine/dt [Drug Therapy], chlorambucil/ae [Adverse Drug Reaction], chlorambucil/cb [Drug Combination], chlorambucil/dt [Drug Therapy], clarithromycin/it [Drug Interaction], cyclophosphamide/cb [Drug Combination], cyclophosphamide/cm [Drug Comparison], cyclophosphamide/dt [Drug Therapy], fludarabine/cb [Drug Combination], fludarabine/cm [Drug Comparison], fludarabine/dt [Drug Therapy], hydrocortisone/dt [Drug Therapy], ibrutinib/cb [Drug Combination], ibrutinib/cm [Drug Comparison], ibrutinib/dt [Drug Therapy], obinutuzumab/cb [Drug Combination], obinutuzumab/dt [Drug Therapy], posaconazole/it [Drug Interaction], ritonavir/it [Drug Interaction], rituximab/ae [Adverse Drug Reaction], rituximab/cb [Drug Combination], rituximab/cm [Drug Comparison], rituximab/dt [Drug Therapy], venetoclax/ae [Adverse Drug Reaction], venetoclax/cb [Drug Combination], venetoclax/cm [Drug Comparison], venetoclax/it [Drug Interaction], venetoclax/dt [Drug Therapy], obinutuzumab/ae [Adverse Drug Reaction], abdominal pain/si [Side Effect], allogeneic hematopoietic stem cell transplantation, anemia/si [Side Effect], article, backache/si [Side Effect], cancer chemotherapy, cancer immunotherapy, cancer recurrence, chronic lymphatic leukemia/dt [Drug Therapy], chronic lymphatic leukemia/th [Therapy], diarrhea/si [Side Effect], drug efficacy, drug metabolism, drug potentiation, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27245
Future Oncology
LibKey Link

مصطلحات الفهرس: human, hypertension/si [Side Effect], lower respiratory tract infection/si [Side Effect], major clinical study, male, nausea/si [Side Effect], neutropenia/si [Side Effect], oropharynx pain/si [Side Effect], overall response rate, overall survival, petechia/si [Side Effect], phase 1 clinical trial, phase 2 clinical trial, pneumonia/si [Side Effect], priority journal, progression free survival, pruritus/si [Side Effect], pseudallescheriasis/si [Side Effect], rash/si [Side Effect], remission, sepsis/si [Side Effect], side effect/si [Side Effect], skin cancer/si [Side Effect], stomach adenocarcinoma/si [Side Effect], thrombocytopenia/si [Side Effect], treatment response, tumor lysis syndrome/si [Side Effect], upper respiratory tract infection/si [Side Effect], Waldenstroem macroglobulinemia/dt [Drug Therapy], hemoglobin/ec [Endogenous Compound], immunoglobulin M/ec [Endogenous Compound], zanubrutinib/ae [Adverse Drug Reaction], zanubrutinib/ct [Clinical Trial], zanubrutinib/dt [Drug Therapy], multicenter study, actinic keratosis/si [Side Effect], adult, aged, anemia/si [Side Effect], arthralgia/si [Side Effect], article, atrial fibrillation/si [Side Effect], backache/si [Side Effect], bacterial arthritis/si [Side Effect], basal cell carcinoma/si [Side Effect], bleeding/si [Side Effect], bronchiectasis/si [Side Effect], cellulitis/si [Side Effect], constipation/si [Side Effect], contusion/si [Side Effect], coughing/si [Side Effect], demography, diarrhea/si [Side Effect], disease exacerbation, drug efficacy, drug safety, drug withdrawal, epistaxis/si [Side Effect], falling, fatigue/si [Side Effect], female, follow up, gastroesophageal reflux/si [Side Effect], headache/si [Side Effect], hepatitis B/si [Side Effect], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/26861
Blood
Click here for full text options
LibKey Link

مصطلحات الفهرس: pruritus/si [Side Effect], randomized controlled trial (topic), rash/si [Side Effect], respiratory tract infection/si [Side Effect], second cancer/si [Side Effect], skin cancer/si [Side Effect], splenomegaly, subdural hematoma/si [Side Effect], thrombocytopenia/si [Side Effect], upper respiratory tract infection/si [Side Effect], urinary tract infection/si [Side Effect], very elderly, Waldenstroem macroglobulinemia/dt [Drug Therapy], bendamustine/dt [Drug Therapy], chlorambucil/dt [Drug Therapy], cisplatin/dt [Drug Therapy], cyclophosphamide/dt [Drug Therapy], dexamethasone/dt [Drug Therapy], enoxaparin/cb [Drug Combination], hemoglobin/ec [Endogenous Compound], hydrocortisone/dt [Drug Therapy], ifosfamide/dt [Drug Therapy], immunoglobulin M/ec [Endogenous Compound], lomustine/dt [Drug Therapy], melphalan/dt [Drug Therapy], methylprednisolone/dt [Drug Therapy], myeloid differentiation factor 88/ec [Endogenous Compound], ofatumumab/dt [Drug Therapy], prednisolone/dt [Drug Therapy], prednisone/dt [Drug Therapy], rituximab/dt [Drug Therapy], zanubrutinib/ae [Adverse Drug Reaction], zanubrutinib/cb [Drug Combination], zanubrutinib/dt [Drug Therapy], zanubrutinib/tm [Unexpected Outcome of Drug Treatment], MYD88 gene, zanubrutinib/pv [Special Situation for Pharmacovigilance], adult, aged, anemia/si [Side Effect], arthralgia/si [Side Effect], article, atrial fibrillation/si [Side Effect], backache/si [Side Effect], basal cell carcinoma/si [Side Effect], bleeding/si [Side Effect], cellulitis/si [Side Effect], clinical article, constipation/si [Side Effect], contusion/si [Side Effect], coughing/si [Side Effect], decreased appetite/si [Side Effect], diarrhea/si [Side Effect], drug dose reduction, drug efficacy, drug safety, drug withdrawal, fatigue/si [Side Effect], female, fever/si [Side Effect], gene mutation, headache/si [Side Effect], hemoptysis/si [Side Effect], herpes zoster/si [Side Effect], human, hypertension/si [Side Effect], hyponatremia/si [Side Effect], infection/si [Side Effect], laceration/si [Side Effect], lymphadenopathy, male, monotherapy, multicenter study (topic), muscle spasm/si [Side Effect], neutropenia/si [Side Effect], opportunistic infection/si [Side Effect], overall survival, peripheral edema/si [Side Effect], phase 3 clinical trial (topic), pneumonia/si [Side Effect], priority journal, progression free survival, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28760
Blood Advances
LibKey Link

مصطلحات الفهرس: human, hypertension/si [Side Effect], lower respiratory tract infection/si [Side Effect], major clinical study, male, nausea/si [Side Effect], neutropenia/si [Side Effect], oropharynx pain/si [Side Effect], overall response rate, overall survival, petechia/si [Side Effect], phase 1 clinical trial, phase 2 clinical trial, pneumonia/si [Side Effect], priority journal, progression free survival, pruritus/si [Side Effect], pseudallescheriasis/si [Side Effect], rash/si [Side Effect], remission, sepsis/si [Side Effect], side effect/si [Side Effect], skin cancer/si [Side Effect], stomach adenocarcinoma/si [Side Effect], thrombocytopenia/si [Side Effect], treatment response, tumor lysis syndrome/si [Side Effect], upper respiratory tract infection/si [Side Effect], Waldenstroem macroglobulinemia/dt [Drug Therapy], hemoglobin/ec [Endogenous Compound], immunoglobulin M/ec [Endogenous Compound], zanubrutinib/ae [Adverse Drug Reaction], zanubrutinib/ct [Clinical Trial], zanubrutinib/dt [Drug Therapy], multicenter study, actinic keratosis/si [Side Effect], adult, aged, anemia/si [Side Effect], arthralgia/si [Side Effect], article, atrial fibrillation/si [Side Effect], backache/si [Side Effect], bacterial arthritis/si [Side Effect], basal cell carcinoma/si [Side Effect], bleeding/si [Side Effect], bronchiectasis/si [Side Effect], cellulitis/si [Side Effect], constipation/si [Side Effect], contusion/si [Side Effect], coughing/si [Side Effect], demography, diarrhea/si [Side Effect], disease exacerbation, drug efficacy, drug safety, drug withdrawal, epistaxis/si [Side Effect], falling, fatigue/si [Side Effect], female, follow up, gastroesophageal reflux/si [Side Effect], headache/si [Side Effect], hepatitis B/si [Side Effect], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/26861
Blood
LibKey Link

مصطلحات الفهرس: drug dose reduction, drug efficacy, drug elimination, drug half life, drug safety, drug tolerability, drug withdrawal, dry throat/si [Side Effect], eczema/si [Side Effect], epistaxis/si [Side Effect], faintness/si [Side Effect], fasting, fatigue/si [Side Effect], female, flu like syndrome/si [Side Effect], gastroenteritis/si [Side Effect], gastroesophageal reflux/si [Side Effect], gingiva pain/si [Side Effect], headache/si [Side Effect], heart palpitation/si [Side Effect], hematoma/si [Side Effect], hepatitis B/dt [Drug Therapy], hepatitis B/si [Side Effect], human, hypertension/si [Side Effect], increased appetite/si [Side Effect], injection site reaction/si [Side Effect], insomnia/si [Side Effect], maculopapular rash/si [Side Effect], male, maximum plasma concentration, mental instability/si [Side Effect], mouth ulcer/si [Side Effect], multiple drug dose, musculoskeletal pain/si [Side Effect], mycosis/si [Side Effect], nausea/si [Side Effect], neck pain/si [Side Effect], nose obstruction/si [Side Effect], oropharynx pain/si [Side Effect], pain/si [Side Effect], petechia/si [Side Effect], pharmacokinetics, phase 1 clinical trial, photosensitivity/si [Side Effect], pigmented nevus/si [Side Effect], positional dizziness/si [Side Effect], priority journal, pruritus/si [Side Effect], randomized controlled trial, rash/si [Side Effect], real time polymerase chain reaction, rhinorrhea/si [Side Effect], single drug dose, skin bruising/si [Side Effect], skin irritation/si [Side Effect], skin manifestation/si [Side Effect], sprain/si [Side Effect], sunburn/si [Side Effect], sweat gland disease/si [Side Effect], thorax pain/si [Side Effect], time to maximum plasma concentration, tonsillitis/si [Side Effect], treatment response, upper abdominal pain/si [Side Effect], virus load, volume of distribution, vomiting/si [Side Effect], wound/si [Side Effect], alanine aminotransferase/ec [Endogenous Compound], hepatitis B core antibody/ae [Adverse Drug Reaction], hepatitis B core antibody/ct [Clinical Trial], hepatitis B core antibody/cm [Drug Comparison], hepatitis B core antibody/cr [Drug Concentration], hepatitis B core antibody/do [Drug Dose], hepatitis B core antibody/dt [Drug Therapy], hepatitis B core antibody/po [Oral Drug Administration], hepatitis B core antibody/pk [Pharmacokinetics], hepatitis B core antigen, hepatitis B surface antigen, hepatitis B(e) antigen, placebo, virus DNA, virus RNA, dysgeusia/si [Side Effect], presyncope/si [Side Effect], abdominal discomfort/si [Side Effect], abdominal distension/si [Side Effect], abdominal pain/si [Side Effect], adult, allergy/si [Side Effect], antiviral activity, area under the curve, article, asthenopia/si [Side Effect], backache/si [Side Effect], catheter infection/si [Side Effect], chronic hepatitis B/dt [Drug Therapy], chronic hepatitis B/si [Side Effect], clinical article, cohort analysis, conjunctivitis/si [Side Effect], constipation/si [Side Effect], controlled study, coughing/si [Side Effect], crackle/si [Side Effect], decreased appetite/si [Side Effect], dehydration/si [Side Effect], diarrhea/si [Side Effect], dizziness/si [Side Effect], drug dose comparison, drug dose increase, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29395
Click here for full text options
LibKey Link

مصطلحات الفهرس: betamethasone/pv [Special Situation for Pharmacovigilance], sitravatinib/pv [Special Situation for Pharmacovigilance], tislelizumab/ae [Adverse Drug Reaction], tislelizumab/dt [Drug Therapy], tislelizumab/iv [Intravenous Drug Administration], tislelizumab/pv [Special Situation for Pharmacovigilance], lichen planus pemphigoides/di [Diagnosis], lichen planus pemphigoides/dt [Drug Therapy], lichen planus pemphigoides/si [Side Effect], erythema, female, histopathology, human, human tissue, immunofluorescence test, inflammatory infiltrate, letter, lichen planus/di [Diagnosis], lichen planus/dt [Drug Therapy], lichen planus/si [Side Effect], lung adenocarcinoma/dt [Drug Therapy], maculopapular rash/dt [Drug Therapy], maculopapular rash/si [Side Effect], metastasis/dt [Drug Therapy], multiple cycle treatment, parakeratosis, pruritus/si [Side Effect], rash/si [Side Effect], stria, betamethasone/dt [Drug Therapy], betamethasone/tp [Topical Drug Administration], complement component C3/ec [Endogenous Compound], emollient agent/dt [Drug Therapy], emollient agent/pv [Special Situation for Pharmacovigilance], emollient agent/tp [Topical Drug Administration], immunoglobulin G/ec [Endogenous Compound], pembrolizumab/ae [Adverse Drug Reaction], pembrolizumab/dt [Drug Therapy], pembrolizumab/iv [Intravenous Drug Administration], pembrolizumab/pv [Special Situation for Pharmacovigilance], pembrolizumab/tm [Unexpected Outcome of Drug Treatment], prednisolone/dt [Drug Therapy], prednisolone/po [Oral Drug Administration], prednisolone/pv [Special Situation for Pharmacovigilance], sitravatinib/dt [Drug Therapy], sitravatinib/po [Oral Drug Administration], acanthosis, aged, blister/si [Side Effect], case report, clinical article, drug withdrawal, Letter

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35367
Australasian Journal of Dermatology
Click here for full text options
LibKey Link

مصطلحات الفهرس: endometrium cancer/di [Diagnosis], endometrium cancer/dt [Drug Therapy], endometrium cancer/et [Etiology], enzyme inhibition, fatigue/si [Side Effect], female, fever/si [Side Effect], gastroesophageal reflux/si [Side Effect], glossodynia/si [Side Effect], hand foot syndrome/si [Side Effect], headache/si [Side Effect], human, hyperkeratosis/si [Side Effect], hypertension/si [Side Effect], hypomagnesemia/si [Side Effect], hypophosphatemia/si [Side Effect], hypotension/si [Side Effect], insomnia/si [Side Effect], intestine obstruction/si [Side Effect], intestine perforation/si [Side Effect], lethargy/si [Side Effect], limb pain/si [Side Effect], major clinical study, male, maximum plasma concentration, maximum tolerated dose, melanoma/di [Diagnosis], melanoma/dt [Drug Therapy], melanoma/et [Etiology], multiple cycle treatment, muscle spasm/si [Side Effect], musculoskeletal chest pain/si [Side Effect], myalgia/si [Side Effect], nausea/si [Side Effect], neutropenia/si [Side Effect], non small cell lung cancer/di [Diagnosis], non small cell lung cancer/dt [Drug Therapy], non small cell lung cancer/et [Etiology], oncogene N ras, oropharynx pain/si [Side Effect], ovary cancer/di [Diagnosis], ovary cancer/dt [Drug Therapy], ovary cancer/et [Etiology], palmoplantar keratoderma/si [Side Effect], pericardial effusion/si [Side Effect], phase 1 clinical trial, photosensitivity/si [Side Effect], pleura effusion/si [Side Effect], positron emission tomography-computed tomography, priority journal, progression free survival, pruritus/si [Side Effect], QT prolongation/si [Side Effect], rash/si [Side Effect], sepsis/si [Side Effect], side effect/si [Side Effect], skin defect/si [Side Effect], skin hypertrophy/si [Side Effect], solid malignant neoplasm, thrombocytopenia/si [Side Effect], thrush/si [Side Effect], thyroid cancer/di [Diagnosis], thyroid cancer/dt [Drug Therapy], thyroid cancer/et [Etiology], thyroid papillary carcinoma/di [Diagnosis], thyroid papillary carcinoma/dt [Drug Therapy], thyroid papillary carcinoma/et [Etiology], treatment duration, upper abdominal pain/si [Side Effect], upper respiratory tract infection/si [Side Effect], urinary tract infection/si [Side Effect], vomiting/si [Side Effect], xerostomia/si [Side Effect], alanine aminotransferase/ec [Endogenous Compound], B Raf kinase/ec [Endogenous Compound], K ras protein/ec [Endogenous Compound], lifirafenib/ae [Adverse Drug Reaction], lifirafenib/ct [Clinical Trial], lifirafenib/cr [Drug Concentration], lifirafenib/do [Drug Dose], lifirafenib/dt [Drug Therapy], lifirafenib/to [Drug Toxicity], lifirafenib/pd [Pharmacology], dizziness/si [Side Effect], abdominal pain/si [Side Effect], adult, aged, alanine aminotransferase blood level, anemia/si [Side Effect], antineoplastic activity, arthralgia/si [Side Effect], article, backache/si [Side Effect], blood level, blood toxicity/si [Side Effect], body weight disorder/si [Side Effect], body weight loss, brain hemorrhage/si [Side Effect], cancer chemotherapy, cancer patient, cancer radiotherapy, cancer staging, cancer survival, chill/si [Side Effect], cohort analysis, colorectal cancer/di [Diagnosis], colorectal cancer/dt [Drug Therapy], colorectal cancer/et [Etiology], constipation/si [Side Effect], coughing/si [Side Effect], decreased appetite/si [Side Effect], dermatitis/si [Side Effect], diarrhea/si [Side Effect], disease exacerbation/si [Side Effect], drug blood level, drug dose increase, drug half life, drug safety, drug tolerability, dry skin/si [Side Effect], dysgeusia/si [Side Effect], dysphonia/si [Side Effect], dyspnea/si [Side Effect], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28975
Journal of Clinical Oncology
Click here for full text options
LibKey Link

مصطلحات الفهرس: drug absorption, drug bioavailability, drug contraindication, drug efficacy, drug metabolism, drug safety, erythema annulare centrifugum/si [Side Effect], erythema multiforme/si [Side Effect], eye examination, gastrointestinal symptom/si [Side Effect], giant cell granuloma/dt [Drug Therapy], glioblastoma/dt [Drug Therapy], glucose 6 phosphate dehydrogenase deficiency, granuloma annulare/dt [Drug Therapy], heart protection, heartburn/si [Side Effect], human, hyperpigmentation/si [Side Effect], hypertransaminasemia/si [Side Effect], hypoglycemia/si [Side Effect], immunomodulation, irritability, leukopenia/si [Side Effect], lichen (disease)/dt [Drug Therapy], lichen planus/dt [Drug Therapy], lichen sclerosus et atrophicus/dt [Drug Therapy], liver toxicity/si [Side Effect], lung cancer/dt [Drug Therapy], lupus vulgaris/dt [Drug Therapy], measles like rash/si [Side Effect], melanoma/dt [Drug Therapy], mood change, morphea/dt [Drug Therapy], mucinosis/dt [Drug Therapy], multiple myeloma/dt [Drug Therapy], nausea/si [Side Effect], necrobiosis lipoidica/dt [Drug Therapy], nightmare/si [Side Effect], nonhuman, outcome assessment, pancreas cancer/dt [Drug Therapy], panniculitis/dt [Drug Therapy], patient monitoring, pharmacodynamics, photodermatosis/dt [Drug Therapy], porphyria cutanea tarda/dt [Drug Therapy], practice guideline, pregnancy, prescription, pruritus/si [Side Effect], psoriasis/si [Side Effect], rash/si [Side Effect], retina maculopathy/si [Side Effect], retinopathy/si [Side Effect], review, risk benefit analysis, risk reduction, sarcoma/dt [Drug Therapy], side effect/si [Side Effect], skin contusion/si [Side Effect], skin sarcoidosis/dt [Drug Therapy], smoking, solid malignant neoplasm/dt [Drug Therapy], Stevens Johnson syndrome/si [Side Effect], systemic lupus erythematosus/dt [Drug Therapy], systemic sclerosis/dt [Drug Therapy], toxic epidermal necrolysis/si [Side Effect], treatment response, urticaria/si [Side Effect], vasculitis/dt [Drug Therapy], visual impairment/si [Side Effect], vomiting/si [Side Effect], cyclosporine/it [Drug Interaction], digoxin/it [Drug Interaction], glucose 6 phosphate dehydrogenase/ec [Endogenous Compound], hydroxychloroquine/ae [Adverse Drug Reaction], hydroxychloroquine/it [Drug Interaction], hydroxychloroquine/dt [Drug Therapy], hydroxychloroquine/pk [Pharmacokinetics], hydroxychloroquine/pd [Pharmacology], methotrexate/it [Drug Interaction], follicular mucinosis/dt [Drug Therapy], lichen planopilaris/dt [Drug Therapy], reticular erythematous mucinosis/dt [Drug Therapy], urticarial vasculitis/dt [Drug Therapy], laboratory test, abdominal distension/si [Side Effect], acute generalized exanthematous pustulosis/si [Side Effect], agranulocytosis/si [Side Effect], alopecia/si [Side Effect], alopecia areata/dt [Drug Therapy], anorexia/si [Side Effect], antineoplastic activity, antiphospholipid syndrome/dt [Drug Therapy], antithrombotic activity, aplastic anemia/si [Side Effect], blood toxicity/si [Side Effect], chronic urticaria/dt [Drug Therapy], dermatology, dermatomyositis/dt [Drug Therapy], diarrhea/si [Side Effect], DRESS syndrome/si [Side Effect], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35375
Australasian Journal of Dermatology
Click here for full text options
LibKey Link